Compare
Compare to the live page
Archived snapshot
External advisory bodies for Health Canada - Canada.ca
2025-04-18T14:44:41.583Z · legacy-hc-2025-04-21
ID 187340
Original URL ↗Live page
Live fetch
2026-02-01T18:24:52.630Z
Status: 200 · Type: text/html;charset=utf-8 · Bytes: 27372
Independent archive · Descriptive changes only; the live page is not archived. Cite the snapshot (/cite).
2 sections changed; 2 added; 2 removed (high-noise change)Main contentChange ratio: 82%+34 / -65 lines2 sections changed
High-noise change: may include navigation/footer updates.
External advisory bodies for Health Canada
In fulfilling its mandate to help Canadians maintain and improve their health, Health Canada seeks information and advice from other people, groups, agencies and governments. This includes seeking advice from experts using external advisory bodies. These bodies are composed of people who are outside of the federal government, chosen for their knowledge, expertise and experience.
In fulfilling its mandate to help people in Canada maintain and improve their health, Health Canada seeks information and advice from other people, groups, agencies and governments. This includes seeking advice from experts using external advisory bodies. These bodies are composed of people who are outside of the federal government, chosen for their knowledge, expertise and experience.
The
The Health Canada Policy on External Advisory Bodies provides direction to those managing external advisory bodies and how to use their advice. The policy also provides stakeholders and members of the public with accessible information on what to expect when Health Canada seeks advice from an external advisory body.
Learn more:
Health Canada Policy on External Advisory Bodies (2022)
provides direction to those managing external advisory bodies and how to use their advice. The policy also provides stakeholders and members of the public with accessible information on what to expect when Health Canada seeks advice from an external advisory body.
Active external advisory bodies
<li><a href="/content/canadasite/en/health-canada/corporate/about-health-canada/public-engagement/external-advisory-bodies/national-pharmacare-committee-experts.html">National Pharmacare Committee of Experts</a></li>
Scientific advisory bodies
National Pharmacare Committee of Experts
Science Advisory Committee on Health Products Containing Cannabis
Science Advisory Committee on Pest Control Products
Scientific Advisory Board on Vaping Products
Scientific Advisory Committee on Digital Health Technology
Scientific Advisory Committee Medical Devices Used in the Cardiovascular System
Scientific Advisory Committee on Health Products for Women
Scientific Advisory Committee on Mental Health Disorders
Scientific Advisory Committee on Oncology Therapies
Scientific Advisory Committee on Pharmaceutical Sciences and Clinical Pharmacology
Scientific Advisory Committee on Respiratory and Allergy Therapies
Other advisory bodies
Chemicals Management Plan Science Committee
Expert Advisory Group on Safer Supply
Implementation Advisory Group (IAG) for the National Strategy for Drugs for Rare Diseases
Review of the Federal Approach to Pandemic Science Advice and Research Coordination
Ministerial Advisory Council on Mental Health
Pest Management Advisory Council
Youth Leadership Team (Substance Use)
Inactive or disbanded external advisory bodies
Scientific advisory bodies
Nutrition Science Advisory Committee
Scientific Advisory Panel on Software as a Medical Device
Other advisory bodies
Advisory Council on the Implementation of National Pharmacare
Appropriate Use Advisory Committee
Canadian Pain Task Force
COVID-19 Testing and Screening Expert Advisory Panel
Expert Advisory Group on Marketing of Opioids
Expert panel:
Cannabis Act
legislative review
Appropriate Use Advisory Committee
Expert Advisory Group on Safer Supply
Science Advisory Committee on Pest Control Products
Chemicals Management Plan Science Committee (CMP)
Ministerial Advisory Council on Mental Health (MACMH)
Paediatric Expert Advisory Committee (PEAC)
Nutrition Science Advisory Committee (NSAC)
Pest Management Advisory Council (PMAC)
Science Advisory Committee on Health Products Containing Cannabis
Scientific Advisory Board on Vaping Products (SAB-VP)
Scientific Advisory Committee on Digital Health Technology (SAC-DHT)
Scientific Advisory Committee Medical Devices Used in the Cardiovascular System (SAC-MDUCS)
Scientific Advisory Committee on Health Products for Women (SAC-HPW)
Scientific Advisory Committee on Oncology Therapies (SAC-OT)
Scientific Advisory Committee on Pharmaceutical Sciences and Clinical Pharmacology (SAC-PSCP)
Scientific Advisory Committee on Respiratory and Allergy Therapies (SAC-RAT)
Youth Leadership Team (Tobacco control and vaping)
Inactive or disbanded external advisory bodies
Industry Advisory Roundtable on COVID-19 Testing, Screening, Tracing and Data Management
Testing and Screening Expert Advisory Panel
Advisory Committee on Animal Uses of Antimicrobials and Impact on Resistance and Human Health
Advisory Council on the Implementation of National Pharmacare
Advisory Council on Traditional Chinese Medicine
Canadian Pain Task Force (CPTF)
Economic Management Advisory Committee (EMAC)
Expert Advisory Committee on Veterinary Natural Health Products (EAC-VNHP)
Expert Advisory Group on Marketing of Opioids
Expert Panel on Immune Globulin Product Supply and Related Impacts in Canada
Expert Panel on MAID and Mental Illness
Expert Task Force on Substance Use
External Advisory Panel on Selective COX-2 Inhibitor NSAIDS (EAP-COX-2)
Industry Advisory Roundtable on COVID-19 Testing, Screening, Tracing and Data Management
External Review of the Federally Funded Pan-Canadian Health Organizations (PCHOs) - Implementation Phase
National Pharmacare Committee of Experts
External Working Group on the Registration and Disclosure of Clinical Trial Information (EWG-CT)
Review of the Federal Approach to Pandemic Science Advice and Research Coordination
Food Expert Advisory Committee (FEAC)
Natural Health Products Program Advisory Committee
Scientific Advisory Committee on Anti-Infective Therapies (SAC-AIT)
Scientific Advisory Committee on Bioavailability and Bioequivalence (SAC-BB)
Scientific Advisory Committee on Cardiovascular Therapies (SAC-CT)
Scientific Advisory Committee on HIV Therapies (SAC-HIVT)
Scientific Advisory Committee on Human Reproductive Therapies (SAC-HRT)
Scientific Advisory Committee on Musculoskeletal Therapies (SAC-MST)
Scientific Advisory Committee on Neurological Therapies (SAC-NT)
Scientific Advisory Panel on Bioequivalence Requirements for Gender-Specific Drug Products (SAP-GSDP)
Scientific Advisory Panel on Bioequivalence Requirements for Modified-Release Dosage Forms (SAP-MRDF)
Scientific Advisory Panel on Diclectin (SAP-Diclectin)
Scientific Advisory Panel on Hepatoxicity (SAP-H)
Scientific Advisory Panel on Isotretinoin (SAP-I)
Scientific Advisory Panel on Isotretinoin Risk Management (SAP-IRM)
Scientific Advisory Panel on Neuropathic Pain (SAP-NP)
Scientific Advisory Panel on Nonprescription Paediatric Cough & Cold Medications (SAP-NPCCM)
Scientific Advisory Panel on Opioid Analgesic Abuse (SAP-OAA)
Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC)
Scientific Advisory Panel on Opioids (SAP-Opioids)
Scientific Advisory Panel on Software as a Medical Device (SAP-SaMD)
Scientific Advisory Panel on Schedule of the Food and Drugs Act (SAP-Sch-A)
Scientific Advisory Panel on Selective Serotonin Reuptake Inhibitors and Serotonin/Norepinephrine Reuptake Inhibitors (SAP-SSRI/SNRI)
Scientific Advisory Panel on the Bioequivalence Requirements for Fentanyl Transdermal Delivery Systems (SAP-FTDS)
Special Access Programme: Expert Advisory Panel
Stakeholder Reference Group on Implementation of Public Release of Clinical Information
Task Force on Cannabis Legalization and Regulation
Page details
Date modified:
2025-12-03
2025-02-14